{{Rsnum
|rsid=1866389
|Gene=THBS4
|Chromosome=5
|position=80065442
|Orientation=minus
|GMAF=0.1359
|Gene_s=THBS4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 56.0 | 36.7 | 7.3
| HCB | 94.1 | 5.9 | 0.0
| JPT | 81.8 | 18.2 | 0.0
| YRI | 81.0 | 19.0 | 0.0
| ASW | 80.7 | 19.3 | 0.0
| CHB | 94.1 | 5.9 | 0.0
| CHD | 87.0 | 13.0 | 0.0
| GIH | 70.7 | 29.3 | 0.0
| LWK | 90.7 | 9.3 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 78.1 | 21.2 | 0.7
| TSI | 66.7 | 30.4 | 2.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22011848
|Title=Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels
}}

{{PMID|18178577}} Polymorphisms in thrombospondin genes and myocardial infarction: a case-control study and a meta-analysis of available evidence.

{{PMID|18682748|OA=1
}} Analysis of 17,576 potentially functional SNPs in three case-control studies of myocardial infarction.

{{GET Evidence
|gene=THBS4
|aa_change=Ala387Pro
|aa_change_short=A387P
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1866389
|overall_frequency_n=1921
|overall_frequency_d=10758
|overall_frequency=0.178565
|n_genomes=20
|n_genomes_annotated=0
|n_haplomes=20
|n_articles=0
|n_articles_annotated=0
|nblosum100=2
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}